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 3,6-anhydro-α-L-galactose (L-AHG) is one of the main monosaccharide 24 
constituents of red macroalgae. In the recently discovered bacterial L-AHG catabolic 25 
pathway, L-AHG is firstly oxidized by an NAD(P)+-dependent dehydrogenase 26 
(AHGD), which is a key step of this pathway. However, the catalytic mechanism(s) of 27 
AHGDs is still unclear. Here, we identified and characterized an AHGD from marine 28 
bacterium Vibrio variabilis JCM 19239 (VvAHGD). The NADP+-dependent VvAHGD 29 
could efficiently oxidize L-AHG. Phylogenetic analysis suggested that VvAHGD and 30 
its homologs represent a new aldehyde dehydrogenase (ALDH) family with different 31 
substrate preferences from reported ALDH families, named the L-AHGDH family. To 32 
explain the catalytic mechanism of VvAHGD, we solved the structures of VvAHGD in 33 
the apo form and in complex with NADP+ and modeled its structure with L-AHG. 34 
Based on structural, mutational, and biochemical analyses, the cofactor channel and the 35 
substrate channel of VvAHGD are identified and the key residues involved in the 36 
binding of NADP+ and L-AHG and in the catalysis are revealed. VvAHGD performs 37 
catalysis by controlling the consecutive connection and interruption of the cofactor 38 
channel and the substrate channel via the conformational changes of its two catalytic 39 
residues Cys282 and Glu248. Comparative analyses of structures and enzyme kinetics 40 
revealed that differences in the substrate channels (in shape, size, electrostatic surface 41 
and residue composition) lead to the different substrate preferences of VvAHGD from 42 
other ALDHs. This study on VvAHGD sheds light on the diversified catalytic 43 
mechanisms and evolution of NAD(P)+-dependent ALDHs.  44 
Keywords: Red macroalgae; 3,6-anhydro-L-galactose; Aldehyde dehydrogenase; 45 
Catalysis; Substrate binding  46 
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Marine algae generate approximately a half of the global primary production (1). 53 
Compared to terrestrial biomass, algae contain higher carbohydrates and lower lignin, 54 
thus making them a good target for the production of biofuels and biochemicals (2,3). 55 
In red macroalgae, the most abundant polysaccharides are agarose and carrageenan. 56 
Agarose is a linear polymer with repeating disaccharide subunits composed of 3-linked 57 
β-D-galactose and 4-linked 3,6-anhydro-α-L-galactose (L-AHG) (4). L-AHG is a 58 
recalcitrant bicyclic sugar, which is unique to red macroalgae (4). Marine bacteria play 59 
an important role in the degradation and cycling of algal polysaccharides in the ocean. 60 
Many bacterial enzymes have been reported to be involved in the degradation of 61 
agarose into its monomeric units, including agarases from the hallmark glycoside 62 
hydrolase (GH) families GH50, GH86 and GH117 (5-7). In contrast, there are only a 63 
few of marine bacteria reported to be capable of utilizing the L-AHG monosaccharides, 64 
including Postechiella marina M091 (8), Vibrio sp. strain EJY3 (9) and Raoultella 65 
ornithinolytica B6-JMP12 (10).  66 
 Recently, the L-AHG catabolic pathway is found in marine bacteria P. marina 67 
M091 (8) and Vibrio sp. strain EJY3 (9). L-AHG is firstly oxidized to 3,6-L-68 
anhydrogalactonate (L-AHGA) by an NAD(P)+-dependent L-AHG dehydrogenase 69 
(AHGD, EC 1.2.1.92) before its assimilation into the central metabolism (8,9). The 70 
oxidation of L-AHG is a key step due to its initiation of the L-AHG pathway. Up to 71 
date, only several AHGDs are biochemically characterized, including the M091_0723 72 
from P. marina M091 (8), the Patl_2553 from Pseudoalteromonas atlantica T6c (8), 73 
and the AHGD from Vibrio sp. strain EJY3 (9). These three enzymes share high 74 
sequence identities ranging from 56% to 66%. Among the three enzymes, the AHGD 75 
from Vibrio sp. strain EJY3 (VejAHGD) is characterized in detail (11,12). The 76 
recombinant VejAHGD displays high substrate specificity to L-AHG, but hardly 77 
oxidizes galactose, D-AHG, L-lactaldehyde or other aldehydes (11). The kinetic 78 
parameters of VejAHGD against L-AHG are also unaffected by the presence of other 79 
sugars such as galactose, neoagarobiose, and agaro-oligosaccharides (12). In addition, 80 




which, however, has not been determined. 82 
 AHGDs belong to the NAD(P)+-dependent aldehyde dehydrogenase (ALDH) 83 
superfamily. ALDHs play a key role in the metabolism of endogenous and exogenous 84 
aldehydes by oxidizing aldehydes to corresponding carboxylic acids with NAD(P)+ as 85 
an electron acceptor (13). ALDHs exist in all three domains of life. Based on sequence 86 
identities, ALDHs have been classified into more than 19 families with different 87 
substrate preferences (14). Until now, many apo and holo structures of ALDHs from 88 
different families have been reported. ALDHs generally function as homodimers or 89 
homotetramers, with each monomer containing a catalytic domain, a cofactor binding 90 
domain, and an oligomerization domain within their structures (13). Monomeric 91 
ALDHs contain two channels in opposite sites, a cofactor channel and a substrate 92 
channel, and the active site is located at the junction of these two channels (15,16). 93 
ALDHs utilize a mechanism involving the nucleophilic residue Cys and the general 94 
base Glu (17,18). During the catalytic process, these two catalytic residues usually 95 
undergo conformational changes, which play a key role in the association/release of the 96 
cofactor/substrate/product (19-21). While the substrate channel and the cofactor 97 
channel in most ALDHs are always connected throughout the catalytic cycle (22-24), 98 
the binding of cofactor and/or substrate in some ALDHs results in the two separate 99 
channels to be connected due to the conformational change of the catalytic residue Cys 100 
(25). In addition to the catalytic residues, the conformational changes of non-catalytic 101 
residues in the substrate channel upon the binding of NAD+ also induce the connection 102 
of two separate channels in the betaine aldehyde dehydrogenase from Staphylococcus 103 
aureus (21). For AHGDs, only the structure of the apo Patl_2553 was deposited in the 104 
Protein Data Bank (PDB) by the New York SGX Research Center for Structural 105 
Genomics team, and this structure was preliminarily analyzed by Sun et al. (26). 106 
However, the catalytic mechanism(s) of AHGDs is still unclear. In addition, the 107 
AHGDs so far reported share relatively high sequence identities (43%-44%) with the 108 
lactaldehyde dehydrogenase from Escherichia coli (EcALDH for short) (24), but have 109 
quite different substrate specificity from EcALDH. The structural basis for their 110 




 In this study, the crystal structures of an AHGD from marine bacterium Vibrio 112 
variabilis JCM 19239 (VvAHGD) are solved in the apo form and in complex with 113 
NADP+. Based on structural and mutational analyses combined with substrate docking, 114 
the catalytic mechanism of VvAHGD is explained. Moreover, via detailed comparative 115 
analyses of structures and enzyme kinetics, the structural basis for the substrate 116 
recognition of VvAHGD is illustrated. Based on our results combined with phylogenetic 117 
analysis, VvAHGD and its homologs are suggested to represent a new ALDH family. 118 
 119 
RESULTS AND DISCUSSION 120 
VvAHGD is an NADP+-dependent L-AHG dehydrogenase 121 
Based on blasting analysis, a gene encoding a putative AHGD (GenBank accession No. 122 
GAL27243) was identified from the genome sequence of Vibrio variabilis JCM 19239, 123 
which was named VvAHGD. The VvAHGD protein consists of 480 amino acid residues 124 
with a calculated molecular mass of 52.6 kDa. VvAHGD lacks an N-terminal signal 125 
peptide sequence based on SignalP 4.1 prediction, consistent with its intracellular 126 
location. Among the reported AHGDs, VvAHGD shares the highest sequence identity 127 
(79%) to VejAHGD (9) and the lowest identity (57%) to Patl_2553 (8). Multiple 128 
sequence alignment suggested that the catalytic residues of VvAHGD are Cys282 and 129 
Glu248 (Fig. 1).  130 
 VvAHGD was then over-expressed in E. coli BL21(DE3) and purified. Because no 131 
commercial L-AHG is available, the crude extract of L-AHG is prepared from 132 
neoagarobioses and used as substrate for enzyme activity assay of recombinant 133 
VvAHGD (Fig. 2). VvAHGD could oxidize L-AHG using both NADP+ and NAD+ as 134 
the cofactor (Fig. 2b). Like VejAHGD (9), VvAHGD preferred NADP+, showing an 135 
activity 3.6-fold higher than that with NAD+. Among the known AHGDs, VvAHGD 136 
showed the highest activity towards L-AHG with a specific activity of 57.4 U/mg (Fig. 137 
2b), approximately 4.0-fold higher than that of VejAHGD (Fig. 2c). Similar to 138 
VejAHGD (11), VvAHGD hardly oxidized lactaldehyde, D-AHG, galactose or glucose. 139 
The optimal temperature for VvAHGD activity towards L-AHG was 40°C (Fig. 3a) and 140 




(Fig. 3c). 142 
Overall structural analysis of VvAHGD 143 
To study the catalytic mechanism of VvAHGD, we solved the crystal structures of 144 
VvAHGD in the apo form (2.70 Å resolution) and in complex with NADP+ (2.37 Å 145 
resolution), by molecular replacement using the structure of Patl_2553 (PDB code 146 
3K2W) as the starting model (56% sequence identity). The statistics for refinement are 147 
summarized in Table 1. Crystals of the apo VvAHGD belong to the P212121 space group, 148 
with four molecules per asymmetric unit (Fig. 4a). Crystals of VvAHGD complexed 149 
with NADP+ (VvAHGD-NADP) belong to the P22121 space group, with two molecules 150 
per asymmetric unit. Gel filtration analysis showed that the apo VvAHGD and the 151 
VvAHGD-NADP complex tend to form large oligomers in solution and that the binding 152 
of NADP+ has no effect on the oligomerization state of VvAHGD (Fig. S1). Gel 153 
filtration analysis is applicable in measuring the oligomerization states of globular 154 
proteins but not for nonglobular proteins. Therefore, dynamic light scattering (DLS) 155 
analysis was conducted to further determine the oligomerization state of VvAHGD, 156 
which suggested that both the apo VvAHGD and its complex form stable dimers in 157 
solution (Fig. 4b). The overall structure of VvAHGD monomer is similar to those of 158 
other ALDHs (Fig. 4c), most closely resembling the structures of Patl_2553 and 159 
EcALDH (PDB code 2HG2), with the root mean square deviations of 0.60 Å (421 160 
monomer Cα atoms) and 0.87 Å (434 monomer Cα atoms), respectively. Like other 161 
ALDHs, monomeric VvAHGD contains three domains, a catalytic domain (Gly250-162 
Gly440), a cofactor binding domain (Gln3-Ala116, His441-Tyr469, and Arg140-163 
Leu249 in the Rossmann fold), and an oligomerization domain (Arg117-Pro139 and 164 
Leu470-Tyr479) (Fig. 4d). Both the catalytic domain and the cofactor binding domain 165 
are built on a topologically related βαβ fold. The catalytic residues Cys282 and Glu248 166 
are located in the catalytic domain and the cofactor binding domain, respectively (Fig. 167 
4d). The oligomerization domain is composed of a three-stranded antiparallel β-sheet, 168 
mainly contributing to the formation of the dimerization surface. The overall structure 169 
of the VvAHGD-NADP complex is similar to that of the apo enzyme with a root mean 170 




The NADP+-binding mode in VvAHGD 172 
In the crystal structure of the VvAHGD-NADP complex, one molecule of NADP+ is 173 
bound in the active site of each monomer, occupying the cofactor channel (Fig. 5a and 174 
5b). The substrate channel is on the opposite side of the cofactor channel. The catalytic 175 
residues Cys282 and Glu248 are located at the junction of these two channels. These 176 
two channels are disconnected in the apo structure of VvAHGD, but connected in the 177 
structure of the VvAHGD-NADP complex (Fig. 5c). The cofactor channel has a wide 178 
opening on the protein surface, which is mostly positively charged to hold the adenosine 179 
monophosphate (AMP) moiety and the pyrophosphate group of NADP+ (Fig. 5a). The 180 
internal part of this channel is negatively charged to accommodate the nicotinamide 181 
riboside moiety of NADP+ (Fig. 5a). In the complex, the cofactor NADP+ adopts an 182 
extended conformation, which is typical for oxidized NADP+ (Fig. 5b). Among the 183 
reported structures of ALDHs, the bound cofactors are found to have three different 184 
conformations, the hydride transfer (27,28), the hydrolysis (22,24) and the out 185 
conformation (24,29). Structural superposition with other ALDHs reveals that the 186 
NADP+ bound in the structure of VvAHGD adopts the hydride transfer conformation.  187 
A detailed comparative structural analysis indicates that residues in the cofactor 188 
channel and the substrate channel have similar conformations in both the apo enzyme 189 
and the complex, except for the two catalytic residues Cys282 and Glu248 (Fig. 5d and 190 
5e). Upon the binding of the cofactor, the nucleophilic Cys282 of VvAHGD is 191 
reoriented towards the substrate channel to be in the attacking conformation (Fig. 5d), 192 
and the side chain of the catalytic Glu248 moves away from the active site to leave 193 
room for the nicotinamide ring of NADP+ (Fig. 5d). The conformational changes of 194 
these two catalytic residues result in the connection of the cofactor channel and the 195 
substrate channel in VvAHGD, which is essential for the nicotinamide ring of NADP+ 196 
to be close to the substrate in the hydride transfer state. Mutation of each of these two 197 
catalytic residues to Ala inactivated the enzyme completely (Fig. 6), supporting their 198 
key roles in the catalysis of VvAHGD.  199 
 In the VvAHGD-NADP complex, NADP+ is stabilized mainly by hydrogen bond 200 




bonds with the hydroxyl group of Ser233 and the main-chain CO group of Gly206, the 202 
hydroxyl group of the ribose ring is hydrogen bonded to the side chain of Lys173 and 203 
the main-chain CO group of Thr147, and the phosphate oxygen atoms are hydrogen 204 
bonded to the side chains of Lys173 and Ser176 and the main-chain NH group of 205 
Gly206. The pyrophosphate group of NADP+ is hydrogen bonded to the hydroxyl group 206 
and the main-chain NH group of Ser227 and to the side chain and the main-chain NH 207 
group of Trp149. For the nicotinamide riboside moiety of NADP+, the hydroxyl groups 208 
of the ribose ring form hydrogen bonds with the carboxyl group of Glu383, and the 209 
nicotinamide ring are hydrogen bonded to the side chain of His449 and the main-chain 210 
CO group of Leu249. Except for residues Ser233 and Leu249, mutation of all the other 211 
residues above to Ala led to a complete loss or significant reduction of the VvAHGD 212 
activity (Fig. 6), suggesting that these residues play key roles in the binding of NADP+. 213 
Residues Ser233 and Leu249 possibly contribute little to the binding of NADP+, 214 
because mutation of these two residues to Ala had no or small impact on both the 215 
specific activity and the kinetic parameters of VvAHGD (Fig. 6 and Table 2). Mutations 216 
S176A and S227A dramatically reduced the kcat values of VvAHGD against both 217 
NADP+ and L-AHG and its affinity to NADP+, but had little impact on its affinity to L-218 
AHG (Table 2), further confirming that residues Ser176 and Ser227 play roles in the 219 
catalysis of VvAHGD through interacting with the cofactor. In addition to hydrogen 220 
bond interactions, hydrophobic interactions also contribute to the binding of the 221 
cofactor involving residues such as Ile146, Gly210, Val214, Met224 and Ile234. 222 
The substrate-binding mode in VvAHGD 223 
To investigate the substrate-binding mode in VvAHGD, we tried to obtain the structure 224 
of VvAHGD binding a substrate. We cocrystallized the wild-type VvAHGD and its 225 
inactive mutant E248A in the presence of NADP+ and the prepared L-AHG. 226 
Unfortunately, no electron density was observed for the substrate. Under aqueous 227 
condition, L-AHG was found to exist in three forms, the open-chain aldehyde, the open-228 
chain hydrate and the fused-ring pyranose (11). Therefore, by molecular docking, we 229 
modeled the structures of the VvAHGD-NADP complex bound with L-AHG in three 230 




(Figs. 6a and S2). In this channel, the aldehyde carbonyl of L-AHG in any form is close 232 
to the thiol group of the catalytic Cys282 and the nicotinamide ring of NADP+ (Figs. 233 
6a and S2), which is important for the hydride transfer from the substrate to the 234 
nicotinamide ring of NADP+. L-AHG in all three forms is hydrogen bonded to the side 235 
chain of Glu443 (Figs. 6b and S2). Mutation of this residue to Ala abolished the 236 
enzymatic activity completely, indicating the key role of Glu443 in the binding of L-237 
AHG (Fig. 6c). Circular dichroism (CD) spectroscopy analysis showed that the 238 
secondary structures of the mutants exhibit little deviation from that of wild-type 239 
VvAHGD (Fig. 6d), indicating that the changes in enzymatic activity and kinetic 240 
parameters of the mutants result from residue substitution rather than structural changes. 241 
The catalytic mechanism of VvAHGD 242 
Based on our structural and biochemical results on VvAHGD combined with reported 243 
catalytic mechanisms of other ALDHs (13,30), we propose the mechanism for 244 
VvAHGD to catalyze the oxidation of L-AHG (Fig. 7). The proposed catalytic 245 
mechanism of VvAHGD involves four steps. Firstly, in the absence of cofactor and 246 
substrate, VvAHGD is in the resting state, in which the catalytic residues Cys282 and 247 
Glu248 adopt the apo conformation, and the cofactor channel and the substrate channel 248 
are disconnected due to the blocking by residues Cys282 and Glu248. Secondly, when 249 
the cofactor and the substrate enter their respective channels, the cofactor channel and 250 
the substrate channel are connected due to the conformational changes of Cys282 and 251 
Glu248. The enzyme is in the hydride transfer state. Glu248 moves away from the 252 
active site (the hydride transfer conformation) to leave room for the accommodation of 253 
the nicotinamide ring of NADP+, and Cys282 is oriented towards the substrate channel 254 
(the attacking conformation), so that the nucleophilic Cys282 could attack the aldehyde 255 
carbonyl of L-AHG to form a tetrahedral intermediate with concomitant hydride 256 
transfer from the intermediate to the nicotinamide ring of NADP+. The binding of the 257 
cofactor leads to the conformational changes of these two catalytic residues, which is 258 
required for the nicotinamide ring of NADP+ to be close to both the substrate and the 259 
catalytic Cys282 in this state. Thirdly, the resulting NADPH leaves the active site for 260 




acts as a general base to activate a water molecule to attack the thioester intermediate. 262 
The enzyme is in the hydrolysis state. The reposition is important for Glu248 to be 263 
situated in an appropriate distance from the substrate and Cys282 to catalyze the 264 
deacylation process. In this state, the cofactor channel and the substrate channel are still 265 
connected, but the opening between these two channels possibly becomes narrow due 266 
to the conformational change of Glu248. Lastly, NADPH and the product L-AHGA are 267 
released from the enzyme. Cys282 is reoriented in the apo conformation resulting in 268 
the interruption of the cofactor channel and the substrate channel. Therefore, VvAHGD 269 
is back to the resting state, ready for the next catalytic cycle (Fig. 7). 270 
 During the catalytic process of reported ALDHs, it is requisite for the catalytic 271 
residues Cys and Glu to transform between different conformations (19-22). In 272 
EcALDH (24) and most other ALDHs (22,23), the substrate channel and the cofactor 273 
channel are always connected throughout the catalytic cycle, which is uninfluenced by 274 
the conformational changes of their catalytic residues. In the succinic semialdehyde 275 
dehydrogenase PpALDH21 from Physcomitrella patens (25) and the 276 
phosphonoacetaldehyde dehydrogenase PhnY from Sinorhizobium meliloti (31), the 277 
distantly related homologs of VvAHGD with sequence identities below 30%, their two 278 
channels in the apo enzymes are found to be separated by the catalytic Cys whose 279 
conformational change upon the binding of the cofactor leads to the connection of the 280 
two separate channels. However, in the catalytic process of VvAHGD, both the two 281 
catalytic residues, Cys282 and Glu248, not only undergo conformational changes, but 282 
also function as gatekeepers between the cofactor channel and the substrate channel. In 283 
VvAHGD, the conformational changes of Cys282 and Glu248 lead to the connection 284 
and interruption of the cofactor channel and the substrate channel, which promotes the 285 
productive binding of NADP+/L-AHG and the efficient release of NADPH and L-286 
AHGA during the catalysis and therefore leads to the high catalytic activity of 287 
VvAHGD. Notably, the two channels in the apo Patl_2553 are connected, suggesting 288 
that the catalytic process of Patl_2553 is different from VvAHGD and that this 289 
difference may result in the enzymatic activity of Patl_2553 different from that of 290 




connection and interruption of the cofactor channel and the substrate channel through 292 
the conformational changes of its two catalytic residues Cys282 and Glu248.  293 
Phylogenetic analysis of L-AHG dehydrogenases 294 
To reveal the evolutionary relationship between VvAHGD and other ALDHs, a 295 
phylogenetic tree was constructed including VvAHGD and its homologs, lactaldehyde 296 
dehydrogenases, succinic semialdehyde dehydrogenases from family ALDH5, betaine 297 
aldehyde dehydrogenases from family ALDH25, cytosolic aldehyde dehydrogenases 298 
from family ALDH2, and retinaldehyde dehydrogenases from family ALDH1 (Fig. 8). 299 
The sequence identities between VvAHGD-like sequences and other ALDHs are in a 300 
range of 33% to 44%. Except for the ALDH2 family cytosolic aldehyde 301 
dehydrogenases with a wide substrate specificity (32), VvAHGD and other ALDHs 302 
(24,33-35) show a relatively narrow substrate specificity. As shown in the tree, different 303 
ALDH branches in the phylogenetic tree display different substrate preferences. 304 
VvAHGD and its homologs form a separate branch in the phylogenetic tree, as a sister 305 
group of lactaldehyde dehydrogenases, indicating that VvAHGD and its homologs 306 
represent a new ALDH family with a different substrate specificity from other ALDHs, 307 
which is named the L-AHGDH family in this study.   308 
Structure comparison of aldehyde dehydrogenases 309 
VvAHGD and its homologs are similar to other ALDHs in both sequence (Fig. 1) and 310 
overall structures (Fig. 4c). However, VvAHGD and other ALDHs display different 311 
substrate preferences towards aldehydes. To reveal the structural basis for their different 312 
substrate specificities, a detailed comparative structural analysis of the active sites 313 
involving the cofactor channel and the substrate channel was carried out. No matter 314 
whether ALDHs utilize NADP+ or NAD+ as a cofactor, their cofactor channels are 315 
similar in shape and size (Fig. 9a). Although the cofactor channels of VvAHGD and 316 
EcALDH are coated by a larger patch of positively charged surface than those of the 317 
ALDH5 and ALDH25 family enzymes, most of the key residues in VvAHGD involved 318 
in the binding of the cofactor are highly conserved in these ALDHs (Fig. 9b and 9c), 319 
which is consistent with a previous report on ALDHs from families ALDH2 and 320 




moiety of NADP+ is replaced by Glu and other residues with a larger side chain in other 322 
ALDHs using NAD+ as a cofactor. It has been documented that the residue Glu at this 323 
position sterically hinders the binding of the phosphate group of NADP+ in the plant 324 
ALDH3 family enzymes (36). Compared to the bound NAD+ in the ALDH25 family 325 
enzyme, the adenine moiety of NADP+ in VvAHGD is closer to the residue Ser233 in 326 
space due to the presence of an additional phosphate group (Fig. 9b). The counterparts 327 
of Ser233 in VvAHGD are larger residues in NAD+-dependent ALDHs such as Lys, Ile 328 
or His (Fig. 9b), suggesting that this residue might also be involved in determining the 329 
cofactor specificity of ALDHs. Based on the residue types of these two positions (Fig. 330 
9c), we can hypothesize that lactaldehyde dehydrogenases and other ALDHs from the 331 
ALDH5 and ALDH25 families are dominated by NAD+-dependent ALDHs, whereas a 332 
large proportion of AHGDs tend to prefer NADP+ as a cofactor.  333 
 In contrast to the conserved cofactor channels, the substrate channels are quite 334 
different in shape, size and electrostatic surface for ALDHs from different families (Fig. 335 
10). Among the ALDHs analyzed, retinaldehyde dehydrogenases in the ALDH1 family 336 
harbor the largest substrate channels to hold the largest aldehyde, retinaldehyde (33,37). 337 
The ALDH2 family enzymes have a wide substrate specificity covering aliphatic and 338 
aromatic aldehydes (32), and therefore their substrate channels are not discussed here. 339 
The substrate channels of succinic semialdehyde dehydrogenases in the ALDH5 family 340 
are positively charged to accommodate negatively charged succinic semialdehydes, 341 
whereas those of betaine aldehyde dehydrogenases in the ALDH25 family are 342 
negatively charged to accommodate positively charged betaine aldehydes (Fig. 10a). 343 
Different from the charged substrate channels of the ALDH5 and ALDH25 enzymes, 344 
VvAHGD and EcALDH have approximately neutral substrate channels (Fig. 10a). 345 
VvAHGD has a large substrate channel with 26 residues lining on the channel surface, 346 
while EcALDH has a small substrate channel with only 17 residues on the channel 347 
surface (Fig. 10b). In EcALDH, the lactate product is stabilized through forming 348 
hydrogen bonds with residues Arg161, Glu251, Glu443 and His449 (24), which 349 
correspond to residues Arg158, Glu248, Glu443 and His449 in VvAHGD (Fig. 10c). 350 




Residue Glu443 has been shown to be involved in the binding of L-AHG in VvAHGD 352 
(Fig. 6). Although key residues involved in the substrate/product binding are conserved 353 
in L-AHG dehydrogenases and lactaldehyde dehydrogenases, VvAHGD shows a 354 
limited activity towards lactaldehyde and vice versa (Fig. 2b and 2d). The substrate 355 
channel of EcALDH contains several conserved residues with large side chains 356 
including Leu100, Phe107 and Phe442 at the channel mouth, and Phe157 and Asn286 357 
at the channel neck (Fig. 10c and 10d), which make the channels of EcALDH-like 358 
ALDHs too narrow for the entry of larger substrates such as L-AHG to the active site. 359 
In contrast, VvAHGD is occupied by small residues corresponding to Val97, Ala104, 360 
Gly442, Ala154, and Thr283 at the equivalent positions of the substrate channel (Fig. 361 
10c), which are conserved in VvAHGD homologs (Fig. 10d), and therefore, VvAHGD 362 
and its homologs have a channel with a wide opening to allow the entry of L-AHG. The 363 
kcat value (0.74 ± 0.02 s-1) of VvAHGD and its affinity to L-lactaldehyde (Km of 3.74 ± 364 
0.22 mM) were much lower than those for L-AHG (Table 2), suggesting that the large 365 
substrate channel of VvAHGD is unfavorable for the binding of the small substrate L-366 
lactaldehyde and therefore the enzyme activity towards L-lactaldehyde is severely 367 
decreased. 368 
CONCLUSION 369 
VvAHGD and its homologs form a separate group in the ALDH superfamily based on 370 
phylogenetic analysis. Biochemical characterization showed that VvAHGD could 371 
efficiently oxidize L-AHG by using NADP+ as cofactor. Structural and mutational 372 
analysis revealed key residues involved in the binding of the cofactor and the substrate 373 
L-AHG and in the catalysis in VvAHGD. During the catalytic process, VvAHGD 374 
performs catalysis by controlling the consecutive connection and interruption of the 375 
cofactor channel and the substrate channel via the conformational changes of its two 376 
catalytic residues Cys282 and Glu248. Differences in the substrate channels (in shape, 377 
size, electrostatic surface and residue composition) lead to the different substrate 378 
preferences of VvAHGD from other ALDHs. Based on our results, we suggest AHGDs 379 
to be a new family of the ALDH superfamily, named the L-AHGDH family. This study 380 




dehydrogenase, which provides a better understanding of bacterial AHGDs in the 382 
degradation and cycling of algal polysaccharides in the ocean.  383 
 384 
EXPERIMENTAL PROCEDURES 385 
Gene synthesis and mutagenesis 386 
The genes encoding VvAHGD (GenBank accession No. GAL27243), VejAHGD 387 
(GenBank accession No. WP_014232205), and EcALDH (GenBank accession No. 388 
P25553) were synthesized by Sangon (Shanghai) co., Ltd, and cloned into the 389 
expression vector pET22b, respectively. To study the roles of some residues in catalysis, 390 
the codons for all the selected residues of VvAHGD were individually replaced with 391 
that for Ala. All of the point mutations in VvAHGD were introduced by a 392 
QuikChangeTM site-directed mutagenesis method (38) using plasmid pET22b-393 
VvAHGD as the template. All of the recombinant plasmids were verified by DNA 394 
sequencing. 395 
Protein expression and purification 396 
All the recombinant plasmids were transformed into E. coli BL21 (DE3), respectively. 397 
E. coli cells were cultured at 37°C in Luria-Bertani medium to OD600 at 0.6, and then 398 
the expression of all recombinant proteins in the cells was induced at 20°C by the 399 
addition of 1 mM isopropyl-D-thiogalactopyranoside. After 20 h induction, cells were 400 
collected and disrupted by high pressure cell cracker (JNBIO) in a binding buffer (50 401 
mM Tris-HCl buffer pH 8.0, 100 mM NaCl and 5 mM imidazole). The recombinant 402 
proteins in the resulting extract were first purified by nickel-nitrilotriacetic acid resin 403 
(Qiagen), and then by gel filtration chromatography on a Superdex- 200 column (GE 404 
Healthcare) with 10 mM Tris-HCl buffer (pH 8.0) containing 100 mM NaCl. Protein 405 
concentrations were determined by Pierce BCA Protein Assay Kit (Thermo Scientific, 406 
USA). 407 
L-AHG preparation 408 
In bacterial agar degradation pathway, NABH is a key enzyme that degrades 409 
neoagarobiose into L-AHG and D-galactose (39). The gene of NABH was cloned into 410 




done by the same method as for VvAHGD. To prepare L-AHG, 1.5 mM neoagarobiose 412 
was hydrolyzed by 5 nM NABH in 100 mL tri-distilled water at 30℃ and 180 rpm for 413 
2 h. After reaction, the mixture was centrifuged at 8228 g for 20 min, and the resulting 414 
supernatant was filtrated in a 5 kDa MWCO ultrafiltration centrifuge tube (Sartorius). 415 
The filtration was then freeze dried, which was used as the crude extract of L-AHG. 416 
Thin layer chromatography analysis of the crude extract of L-AHG was performed by 417 
following the method described by Yun et al. (40). The quantitation of L-AHG in the 418 
crude extract was determined by gas chromatography-mass spectrometry (GC-MS) 419 
using D-AHG (Sigma) as the standard. The derivatization of samples and the 420 
implementation of GC-MS was performed by following the method described by Yun 421 
et al. (40). 422 
Biochemical characterization 423 
The crude extract of L-AHG was used as the substrate for enzymatic activity assays. 424 
The standard reaction system (1 mL) contained 0.99 nM VvAHGD, 3.52 mM L-AHG 425 
and 1.5 mM NADP+ in 20 mM Tris-HCl (pH 7.0). After incubation at 40°C for 20 min, 426 
the reaction was terminated by heating at 95°C for 1 min, and then the absorbance of 427 
the reaction mixture was measured at 340 nm. One unit of enzyme (U) is defined as the 428 
amount of enzyme required to produce 1 μmol NADPH per min. The optimum 429 
temperature was measured in the temperature range of 0℃ to 60℃ at pH 7.0. The 430 
optimum pH of VvAHGD was measured at 40℃ in Britton-Robinson buffers ranging 431 
from pH 5.0 to pH 10.0. The effect of NaCl on VvAHGD activity was determined at 432 
NaCl concentrations ranging from 0 to 2.0 M under optimal conditions. L-AHG, L-433 
lactaldehyde, D-AHG, D-galactose and glucose were used as substrates for the enzyme 434 
specificity assays under different cofactors. Enzyme kinetic assays of VvAHGD and its 435 
mutants against NADP+ were carried out in 20 mM Tris-HCl buffer (pH 7.0) using 436 
NADP+ at concentrations from 0 to 4.8 mM and L-AHG at a fixed concentration of 437 
3.52 mM. Enzyme kinetic assays of VvAHGD and its mutants against L-AHG were 438 
carried out using L-AHG at concentrations from 0 to 4.4 mM and NADP+ at a fixed 439 
concentration of 1.5 mM. Kinetic parameters were calculated by nonlinear regression 440 




The activities of VejAHGD and EcALDH towards L-AHG or L-lactaldehyde were 442 
assayed with different cofactors, at 30℃ in 20 mM Tris-HCl (pH 7.0) buffer (11) and 443 
at 25℃ in 20 mM Tris-HCl (pH 8.0) buffer (26,41), respectively. 444 
DLS and CD spectroscopy assays 445 
The DLS experiment was carried out on Dynapro Titan TC (Wyatt Technology, America) 446 
at 4℃. The VvAHGD protein concentration used was 1 mg/mL in 10 mM Tris-HCl (pH 447 
8.0) buffer containing 100 mM NaCl, and the data were analyzed by the dynamics 7. 0. 448 
1 software. The secondary structures of VvAHGD and its mutants were detected at 25°C 449 
using a J-810 CD spectropolarimeter (JASCO). CD spectra were collected from 200 to 450 
250 nm at a scanning rate of 200 nm/min with a path length of 0.1 cm. The concentration 451 
of all proteins was 0.5 mg/mL in 10 mM Tris-HCl buffer (pH 8.0) containing 100 mM 452 
NaCl. 453 
Crystallization, data collection, and structure determination 454 
The protein concentration of VvAHGD for crystallization was 5.0 mg/ml in 10 mM 455 
Tris-HCl (pH 8.0) containing 100 mM NaCl. To obtain the crystals of the VvAHGD-456 
NADP complex, VvAHGD was mixed with NADP+ at a molar ratio of 1: 4 and then 457 
incubated at 4°C for 1 h before crystallization. The crystals of both the apo VvAHGD 458 
and the VvAHGD-NADP complex suitable for x-ray diffraction were obtained at 4°C 459 
after 2 weeks in the buffer containing 0.2 M NaAC·3H2O, 0.1 M sodium cacodylate 460 
trihydrate (pH 6.5), and 30% (w/v) PEG 8,000 by the hanging-drop vapor diffusion 461 
method. All the X-ray diffraction data of crystals were collected on the BL18U1 462 
beamline at Shanghai Synchrotron Radiation Facility. The initial diffraction data sets 463 
were integrated by the HKL3000 program (42). The crystal structure of VvAHGD was 464 
solved by molecular replacement using the CCP4 suite, with the structure of Patl_2553 465 
(PDB code 3K2W) as the staring model. Subsequent refinement was performed using 466 
Coot (43) and Phenix (44). Structure of the VvAHGD-NADP complex was determined 467 
using VvAHGD as a staring model. All structure figures were generated using PyMOL.  468 
Molecular docking 469 
Schrödinger software (https://www.schrodinger.com/) was used to conduct the 470 




LigPrep (LigPrep, Schrödinger, LLC, New York, NY, 2019) to obtain its low energy 472 
three dimensional conformers. The crystal structure of the VvAHGD-NADP complex 473 
was optimized by the Protein Preparation Wizard in Maestro to remove crystallographic 474 
water molecules, add hydrogen atoms, and assign partial charges and protonation states. 475 
L-AHG was then docked into the binding site of the minimised VvAHGD-NADP 476 
complex using the Glide (45) with the standard precision scoring mode. The docking 477 
grid box for L-AHG was generated using the binding site identified by the SiteMap. In 478 
molecular docking, the candidate solution with the lowest binding energy was chosen. 479 
Accession codes 480 
The structures of the apo VvAHGD and the VvAHGD-NADP complex have been 481 
deposited in PDB under the accession numbers 6J75 and 6J76, respectively. 482 
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FIGURE LEGENDS 661 
Fig. 1. Multiple-sequence alignment of VvAHGD and its homologs and EcALDH. 662 
Using ESPript, the secondary structures of VvAHGD are shown above alignment and 663 
those of EcALDH under alignment. Helices are indicated by springs, strands by arrows, 664 
turns by TT letters, and 310 helices by η letters. Identical residues are shown in white 665 
on a black background, and similar residues are in bold black. Green circles indicate 666 
key catalytic residues conserved in ALDHs. Red triangles indicate key residues of 667 
VvAHGD involved in the binding of the cofactor NADP+ and the substrate L-AHG.  668 
Fig. 2. Substrate specificity analyses of VvAHGD, VejAHGD and EcALDH with 669 
different cofactors. (a) Thin layer chromatography analysis of the crude extract of L-670 
AHG. The crude extract of L-AHG prepared from neoagarobioses comprises L-AHG 671 
and D-galactose. Lane 1, the standards of D-AHG, neoagarobiose and D-galactose; 672 
lanes 2 and 3, the prepared crude extract of L-AHG. (b) Substrate specificity analysis 673 
of VvAHGD at 40℃ in 20 mM Tris-HCl (pH 7.0) buffer. (c) Substrate specificity 674 
analysis of VejAHGD at 30℃ in 20 mM Tris-HCl (pH 7.0) buffer. (d) Substrate 675 
specificity analysis of EcALDH at 25℃ in 20 mM Tris-HCl (pH 8.0) buffer. The data 676 
shown in (b)-(d) are from triplicate experiments (mean ± S.D.). 677 
Fig. 3. Effect of temperature (a), pH (b) and NaCl (c) on the activity of VvAHGD. 678 
In (a)-(c), the highest activity of VvAHGD at 40℃ (a), at pH 7.0 (b) and in 0 M NaCl 679 
(c) was taken as 100%, respectively. The data shown in (a)-(c) are from triplicate 680 
experiments (mean ± S.D.). 681 
Fig. 4. Structural analysis of VvAHGD. (a) The structure of tetrameric VvAHGD in 682 
one asymmetric unit. (b) DLS analysis of the molecular mass of VvAHGD. VvAHGD 683 
monomer has a calculated molecular mass of 52.6 kDa. DLS analysis indicated that 684 
VvAHGD forms dimers in solution. (c) Superimposition of VvAHGD and other ALDHs. 685 
VvAHGD is colored in cyan, EcALDH (PDB code 2HG2) in magenta, the succinic 686 
semialdehyde dehydrogenase (PDB code 2W8R) in yellow, and the betaine aldehyde 687 
dehydrogenase (PDB code 4MPY) in green. (d) Monomeric structure of VvAHGD. The 688 
cofactor-binding domain is colored in yellow, the catalytic domain in green, and the 689 




shown in sticks. The loop containing the catalytic residue Cys282 is colored in magenta.  691 
Fig. 5. Analyses of the VvAHGD structure in complex with NADP+ and the 692 
important residues involved in NADP+ binding. (a) Electrostatic surface view of the 693 
VvAHGD-NADP complex. NADP+ is shown as yellow sticks. (b) Cartoon view of the 694 
overall structure of VvAHGD-NADP complex. NADP+ is shown as yellow sticks and 695 
the corresponding 2Fo-Fc electron density map is shown at 1.0 σ. (c) Comparison of the 696 
catalytic tunnels in the apo and the NADP+-bound VvAHGD. The catalytic residues 697 
Cys282 and Glu248 are shown as cyan sticks. The binding of NADP+ induces structural 698 
changes of VvAHGD in the active site, leading to a connection between the cofactor 699 
channel and the substrate channel. (d) Superimposition of the active sites of the apo 700 
(grey) and NADP+-bound (cyan) VvAHGD. The catalytic residues Cys282 and Glu248 701 
are shown as magenta sticks in the NADP+-bound structure, and as grey sticks in the 702 
apo structure. (e) Superimposition of the potential NADP+-binding residues in the apo 703 
(grey) and the NADP+-bound (cyan) VvAHGD.  704 
Fig. 6. Analysis of the key residues in VvAHGD for substrate binding and 705 
mutational analysis of the identified key residues in VvAHGD. (a) Electrostatic 706 
surface view of the NADP+-bound VvAHGD docked with the substrate L-AHG in open-707 
chain aldehyde form. The substrate is shown as green sticks, and the cofactor as yellow 708 
sticks. (b) Detailed structure of the NADP+-bound VvAHGD docked with L-AHG. 709 
Residues involved in the binding and catalysis of L-AHG are shown as cyan sticks. The 710 
substrate is shown as green sticks, and the cofactor as yellow sticks. (c) Enzymatic 711 
activities of the mutants of VvAHGD. The activity of wild-type VvAHGD was defined 712 
as 100%. The graph shows data from triplicate experiments (mean ± S.D.). (d) CD 713 
spectra of wild-type VvAHGD and its mutants. 714 
Fig. 7. A proposed mechanism for VvAHGD to catalyze the oxidation of L-AHG 715 
with NADP+ as a cofactor. Electron transfer is shown as red arrows. The cofactor 716 
channel and the substrate channel are located on the opposite sides of the catalytic 717 
residues Cys282 and Glu248. The borders of these two channels are shown as dashed 718 
lines. The gap within the dashed line represents the opening of the corresponding 719 




The cofactor channel and the substrate channel are disconnected due to the blocking by 721 
the catalytic residues Cys282 and Glu248. (b) The hydride transfer state. When the 722 
cofactor and the substrate enter their respective channels, Cys282 and Glu248 undergo 723 
conformational changes, and thus the nucleophilic Cys282 could attack the L-AHG 724 
substrate to form a tetrahedral intermediate with concomitant hydride transfer from the 725 
intermediate to NADP+. In this state, the cofactor channel and the substrate channel are 726 
connected due to the conformational changes of Cys282 and Glu248. (c) The hydrolysis 727 
state. The resulting NADPH moves away from the active site, leaving room for the 728 
catalytic Glu248 to hydrolyze the thioester intermediate. In this state, the cofactor 729 
channel and the substrate channel are still connected, but the opening between these 730 
two channels possibly becomes narrow due to the conformational change of Glu248. 731 
(d) Back to the resting state. NADPH and the product are released, and the enzyme 732 
molecule returns to the resting state.  733 
Fig. 8. Phylogenetic analysis of VvAHGD and other ALDHs. The tree was 734 
constructed by the neighbor-joining method with a Jones-Taylor-Thornton (JTT) 735 
matrix-based model using 428 amino acid positions. Bootstrap analysis of 1,000 736 
replicates is conducted and values above 50% are shown. The structural formula(s) of 737 
the main substrate(s) catalyzed by ALDHs is also shown for each family. Sequence 738 
identities shared by VvAHGD and other ALDHs range from 33% to 79%. 739 
Fig. 9. Structural comparison of the cofactor channels of ALDHs from different 740 
families. (a) Comparison of the electrostatic potential surfaces of the cofactor channels 741 
of ALDHs from different families. The NAD+/NADP+ cofactor is shown as sticks. In 742 
the structure of the selected ALDH5 succinic semialdehyde dehydrogenase (PDB code 743 
2W8R), only the ADP moiety of the NAD+ cofactor is observed. (b) Superposition of 744 
the cofactor channels of ALDHs from different families. Residues that form hydrogen 745 
bonds with the cofactor are shown as sticks, and colored in cyan for VvAHGD, in 746 
magenta for EcALDH (PDB code 2IMP), in yellow for the ALDH5 succinic 747 
semialdehyde dehydrogenase (PDB code 2W8R), and in green for the ALDH25 betaine 748 
aldehyde dehydrogenase (PDB code 4MPY). NADP+ bound in VvAHGD is shown as 749 




For residues conserved in all enzymes, only the residue positions of VvAHGD are 751 
shown in black. Residues that recognize NAD+ and NADP+ are boxed. (c) An overview 752 
of conservation of residues forming the cofactor channels of ALDHs from different 753 
families. Residues are numbered according to VvAHGD. Residues surrounding the 754 
nicotinamide riboside, diphosphate and adenosine/adenylate moieties of the 755 
NAD+/NADP+ cofactor are marked by solid circles, open squares and open circles, 756 
respectively. Sequence logos were made using WebLogo 757 
(http://weblogo.threeplusone.com). 758 
Fig. 10. Structural comparison of the substrate channels of ALDHs from different 759 
families. (a) Comparison of the electrostatic potential surfaces of the substrate channels 760 
(marked by yellow circles) of selected ALDHs with different substrate specificities. (b) 761 
Close-ups of the entrances of the substrate channels of VvAHGD and EcALDH. 762 
Residues forming the substrate channels of VvAHGD and EcALDH are shown as cyan 763 
and magenta sticks, respectively. For VvAHGD, the modeled L-AHG substrate is shown 764 
as yellow sticks. For EcALDH, the lactate product is shown as green sticks. (c) 765 
Superposition of the substrate channels of VvAHGD and EcALDH. The modeled L-766 
AHG substrate is shown as yellow sticks. (d) An overview of conservation of residues 767 
forming the substrate channels of AHGDs and lactaldehyde dehydrogenases. Residues 768 
are numbered according to VvAHGD. Residues forming the substrate channels of 769 
lactaldehyde dehydrogenases are marked by solid circles. Sequence logos were made 770 
using WebLogo (http://weblogo.threeplusone.com). 771 




TABLE 1 Diffraction data and refinement statistics of the apo VvAHGD and the 773 
VvAHGD-NADP complex. 774 
Parameters VvAHGD VvAHGD-NADP 
Diffraction data   
Space group P212121 P22121 
Unit cell   
a, b, c (Å) 103.39, 132.36, 159.38 76.38, 90.74, 149.05 
α, β, γ (°) 90.00, 90.00, 90.00 90.00, 90.00, 90.00 
Resolution (Å) 50.00-2.70 (2.79-2.70)a 50.00-2.37 (2.45-2.37) 
Redundancy 12.2 (11.9) 13.3 (12.8) 
Completeness (%) 99.0 (100.0) 99.0 (97.6) 
Rmerge (%)b 17.4 (43.1) 16.5 (34.0) 
I/σI 27.5 (7.2) 44.3 (15.3) 
Refinement statistics   
  Resolution (Å) 47.24-2.70 (2.74-2.70) 45.98-2.37 (2.42-2.37) 
  Number of reflections 60214 42552 
R-factor (%) 16.1 16.3 
Free R-factor (%) 21.1 20.5 
Number of atoms   
  Protein 14684 7350 
  Solvent 407 560 
  Ligands  96 
Average B-factor (Å2)   
  Protein 24.82 20.00 
  Solvent 25.14 27.01 
  Ligands  17.24 
RMSD from ideal 
geometry 
  
Bond lengths (Å) 0.010 0.007 
Bond angles (°) 1.15 0.86 
Ramachandran plot (%)   
Favoured 95.84 96.21 
Allowed 4.00 3.68 
Outliers 0.16 0.11 
a Numbers in parentheses refer to data in the highest resolution shell. 775 
b Rmerge=∑hkl∑i|I(hkl)i - <I(hkl)>|/∑hkl∑i<I(hkl)i> 776 




TABLE 2 Kinetic parameters of VvAHGD and its mutants against the cofactor 778 
NADP+ and the substrate L-AHG. 779 
Enzyme 
NADP+a  L-AHGb 
Km kcat kcat/Km  Km kcat kcat/Km 
 mM s-1 mM-1 s-1  mM s-1 mM-1 s-1 
Wild Type 0.33 ± 0.03 69.09 ± 3.04 209.36  1.20 ± 0.08 58.29 ± 2.63 48.58  
S176A 1.11 ± 0.16 19.15 ± 1.61 17.25  1.45 ± 0.11 10.67 ± 0.68 7.36  
S227A 0.58 ± 0.02 44.55 ± 0.88 76.81  1.26 ± 0.04 35.99 ± 0.86 28.56 
S233A 0.38 ± 0.05 75.9 ± 4.01 199.74  1.35 ± 0.03 63.18 ± 1.26 46.80  
L249A 0.41 ± 0.11 63.34 ± 5.42 154.49  1.11 ± 0.05 52.77 ± 9.31 47.54  
a To measure the kinetic parameters of VvAHGD and its mutants against the cofactor 780 
NADP+, reactions were conducted in triplicate in 20 mM Tris-HCl buffer (pH 7.0) using NADP+ 781 
over a concentration range of 0-4.8 mM and L-AHG at a fixed concentration of 3.52 mM. 782 
 b To measure the kinetic parameters of VvAHGD and its mutants against L-AHG, reactions 783 
were conducted in triplicate in 20 mM Tris-HCl buffer (pH 7.0) using L-AHG over a 784 
concentration range of 0-4.4 mM and NADP+ at a fixed concentration of 1.5 mM.  785 
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Fig. S1. Gel filtration analysis of the apo VvAHGD and the VvAHGD-NADP complex. 820 
VvAHGD monomer has a calculated molecular mass of 52.6 kDa. Two protein size 821 







Fig. S2. Detailed structure of the NADP+-bound VvAHGD docked with L-AHG in 826 
pyranose (a) or hydrated form (b). Residues involved in the binding and catalysis of L-827 
AHG are shown as cyan sticks. The substrate is shown as green sticks, and the cofactor 828 
as yellow sticks. 829 
 830 
